Skip to main content

Study

Glucosamine and Chondroitin May Help Ease Joint Pain in Seniors

A review suggests glucosamine and chondroitin supplements could reduce osteoarthritis and joint pain in older adults.

Joint HealthSupplement
Study Credibility: High7.5/10From a trusted journalProperly designed studyResults verified
PublishedApr 2026Last reviewedOct 2026
Email this

Summary

In plain language

A recent study reviewed the effects of glucosamine and chondroitin supplements on joint health, particularly for seniors dealing with osteoarthritis (OA). Researchers found that these supplements may help reduce joint pain and improve function in those with OA, especially when both are used together. With over 100 studies reviewed, many showed positive results, particularly in older adults. While some studies did not find a significant benefit, the overall evidence suggests potential improvements in pain and joint health. This could be a promising option for seniors looking to manage joint pain, though it's important to discuss with a healthcare provider to determine if it's right for you.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study systematically reviewed existing research on glucosamine and chondroitin. Researchers analyzed 146 studies involving these supplements, focusing on their effectiveness in relieving joint pain and improving joint health.

  • The study included trials with thousands of participants, with most showing positive results for osteoarthritis and joint pain.

  • Common doses were 1500 mg of glucosamine and 1200 mg of chondroitin per day, often used together for better results.

  • While many studies showed benefits, some did not, particularly with conditions like rheumatoid arthritis.

Seniors considering these supplements should discuss them with their healthcare provider to ensure they are appropriate for their individual needs.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study scored well in study design and transparency due to its systematic review methodology and adherence to PRISMA guidelines. Bias control was limited by the initial single-researcher quality assessment. The absence of journal information affected the journal quality score. The study is relevant to the target population of seniors.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control3.3/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

This systematic review evaluates the efficacy and safety of glucosamine and chondroitin in joint health, particularly osteoarthritis, in older adults. It includes 146 studies, with a majority being RCTs, and reports positive outcomes for efficacy and minimal safety concerns.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.